Replies to post #42827 on Humanigen Inc (fka HGENQ)

[cowtown jay]

Distributing payments to creditors is only part of the Liquidating Trustee's function. Making a Distribution to existing equity holders is also part of his function. I don't know how he can do that, if our float is 192% of our OS.

I see divergent paths chosen by the judge and the Liquidating Trustee. If the judge is right, which appears likely to me, then there is no need for the Liquidating Trustee.

Hopefully, we'll hear news including Sanofi, the PREACH-M and RATinG trials, and Novavax, before the Liquidating Trustee proceeds much further.

[cowtown jay]

I previously discussed the market's response to our LIVE- AIR topline data (TLD) which allowed me to sell shares for an average price in the $28 range. To now reach a Milestone Event, as the court deems is likely, based on amending the Asset Purchase Agreement, would require receipt of a BLA or regulatory approval, and that would have a greater share price reaction than the news of our TLD.

Even non-regulatory news, such as a merger leading to a business relationship with Sanofi/Novavax, would cause a spike in the share price. Given that I think Humanigen has control of about 90% of the shares they have issued, here again, more than enough profit could be generated by the company selling shares into that news, to pay off all financial obligations.

I am convinced that the positive events I just outlined will transpire. It doesn't make sense that the company would deal us out of the reward following good news. Payment in full to creditors would amount to a pittance of what would be gained in a short squeeze.